大肠直肠癌筛检市场（按筛检测试、最终用户和地区划分）

2025 年全球大肠直肠癌筛检市场规模估计为 165.7 亿美元，预计到 2032 年将达到 271.5 亿美元，2025 年至 2032 年的复合年增长率为 7.3%。

数字。 2025 年各地区大肠癌筛检市场占有率（%）

大肠直肠癌 (CRC) 是全球最常见的癌症之一。当结肠或直肠的正常上皮细胞变成癌细胞时，就会发生 CRC。多种因素会增加 CRC 的风险，包括年龄、饮食、生活方式和遗传条件。筛检测试可以帮助早期发现癌症，特别是对于高风险族群。全球范围内为传播认识和提供改进的筛检技术而做出的努力预计将推动大肠癌筛检市场的成长。

市场动态

各国政府和癌症组织不断提高的倡议预计将推动全球大肠癌筛检市场的成长。例如，美国的国家大肠直肠癌宣传月等项目透过社群媒体宣传活动筛检的重要性。然而，偏远地区筛检测试的机会有限以及与测试相关的社会耻辱可能会阻碍市场的成长。基于血液的生物标记测试等非侵入性诊断方法的开发为市场发展提供了有利可图的机会。

研究的主要特点

• 本报告对全球结直肠癌筛检市场进行了详细分析，并提供了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%），假设基准年为 2024 年。
• 它还强调了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
• 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
• 全球大肠癌筛检市场的主要企业是根据公司亮点、产品系列、关键亮点、绩效和策略等参数进行的分析。
• 主要企业包括 Polymedco Inc. Ltd.、Sysmex Corporation、Siemens Healthineers AG、Quidel Corporation、Novigenix SA、Hemosure Inc.、Exact Sciences Corp.、Epigenomics Inc.、Olympus Corporation、Clinical Genomics Technologies Pty Ltd.、Clinical Genomics 和 Guardant Health, Inc.
• 本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
• 全球大肠直肠癌筛检市场迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过全球结直肠癌筛检市场分析中使用的各种策略矩阵来促进他们的决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• 一致的机会图 (COM)

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 影响分析
• 流行病学
• 市场趋势
• 监管情景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

4. 全球大肠直肠癌检测市场 - 冠状病毒 (COVID-19) 大流行的影响

• 整体影响
• 政府倡议
• COVID-19 市场影响

5. 2020 年至 2032 年全球大肠癌筛检市场（依筛检测试划分）（十亿美元）

• 介绍
• 粪便检验
• 大肠镜检查
• CT结肠成像
• 柔性乙状结肠镜检查
• 其他的

6. 2020-2032 年全球大肠癌筛检市场（以最终用户划分）（十亿美元）

• 介绍
• 医院
• 专科门诊
• 其他的

7. 2020 年至 2032 年全球大肠癌筛检市场（按地区划分）（十亿美元）

• 介绍
• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第八章 竞争格局

• 公司简介
  • Polymedco Inc.
  • Eiken Chemical Co. Ltd.
  • Sysmex Corporation
  • Siemens Healthineers AG
  • Quidel Corporation
  • Novigenix SA
  • Hemosure Inc.
  • Exact Sciences Corp.
  • Epigenomics Inc.
  • Olympus Corporation
  • Clinical Genomics Technologies Pty Ltd.
  • Clinical Genomics
  • Guardant Health, Inc.
  • Hemosure Inc.
  • Geneoscopy, Inc.

第 9 章分析师建议

• 兴衰
• 一致的机会地图

第十章参考文献与调查方法

• 参考
• 调查方法

Global Colorectal Cancer Screening Market is estimated to be valued at USD 16.57 Bn in 2025 and is expected to reach USD 27.15 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032.

Figure. Colorectal Cancer Screening Market Share (%), By Region 2025

Colorectal cancer (CRC) is one of the most commonly diagnosed cancers globally. It arises from the transformation of normal epithelial cell lining in the colon or rectum into cancerous tumors. Several factors such as age, diet, lifestyle and genetic conditions can increase the risk of developing CRC. Screening tests help in early detection of cancer, especially in high risk individuals. Global initiatives to spread awareness and availability of improved screening technologies are expected to drive the colorectal cancer screening market growth.

Market Dynamics:

Rising awareness initiatives by governments and cancer organizations is expected to drive the colorectal cancer screening market growth globally. For example, programs such as the National Colorectal Cancer Awareness Month in the U.S. promotes the importance of screening tests via social media campaigns. However, limited access to screening tests in remote areas and social stigma associated with the tests can hamper the market growth. Development of non-invasive diagnostic approaches such as blood-based biomarker tests offers lucrative opportunities for the market growth.

Key Features of the Study:

• This report provides an in-depth analysis of the global colorectal cancer screening market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global colorectal cancer screening market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this includes Polymedco Inc., Eiken Chemical Co. Ltd., Sysmex Corporation, Siemens Healthineers AG, Quidel Corporation, Novigenix SA, Hemosure Inc., Exact Sciences Corp., Epigenomics Inc., Olympus Corporation, Clinical Genomics Technologies Pty Ltd., Clinical Genomics, Guardant Health, Inc., Hemosure Inc., Geneoscopy, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global colorectal cancer screening market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global colorectal cancer screening market.

Detailed Segmentation-

• By Screening Tests:
  • Stool-based Tests
  • Colonoscopy
  • CT Colonography
  • Flexible Sigmoidoscopy
  • Others
• By End User:
  • Hospitals
  • Specialty Clinics
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Polymedco Inc.
  • Eiken Chemical Co. Ltd.
  • Sysmex Corporation
  • Siemens Healthineers AG
  • Quidel Corporation
  • Novigenix SA
  • Hemosure Inc.
  • Exact Sciences Corp.
  • Epigenomics Inc.
  • Olympus Corporation
  • Clinical Genomics Technologies Pty Ltd.
  • Clinical Genomics
  • Guardant Health, Inc.
  • Hemosure Inc.
  • Geneoscopy, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Screening Tests
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Epidemiology
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Colorectal Cancer Screening Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Colorectal Cancer Screening Market, By Screening Tests, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Stool-based Tests
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Colonoscopy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• CT Colonography
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Flexible Sigmoidoscopy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Colorectal Cancer Screening Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Specialty Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Colorectal Cancer Screening Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Screening Tests, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Screening Tests, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Screening Tests, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Screening Tests, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Screening Tests, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Screening Tests, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • Polymedco Inc.*
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eiken Chemical Co. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sysmex Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Siemens Healthineers AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Quidel Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Novigenix SA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Hemosure Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Exact Sciences Corp.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Epigenomics Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Olympus Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Clinical Genomics Technologies Pty Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Clinical Genomics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Guardant Health, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Hemosure Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Geneoscopy, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact